Deutsche Bank raised the firm’s price target on Edwards Lifesciences (EW) to $94 from $85 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences: Strong Financial Performance and Strategic Advancements Drive Buy Rating
- Edwards Lifesciences price target raised to $90 from $83 at Piper Sandler
- Edwards Lifesciences Announces Leadership Change in TAVR Division
- Strong Growth Potential for Edwards Lifesciences: Buy Rating Affirmed by Analyst Brandon Vazquez
- Edwards Lifesciences Reports Strong Q2 Growth